AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
33. B-Cell Depleting Therapies and COVID-19
ACR on Air
The Risks of B Cell Depleting Therapies for COVID
Once the message was out there that B cell depleting therapies may place patients at increased risk of poor COVID outcomes, did you change your clinical practice in prescribing these drugs? You know, I love me some B cell depletion. And we use a lot of retuxanab in my lupus patients. We have a predominantly black population here in St. Louis and it seems to work just wonderfully for the vast majority of them. Of course, the most dangerous situation is not knowing what you don't know.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode